CRISPR’s Progress for Patients: Clinical Development of Therapies

10:00 AM - 10:30 AM (EST), Wednesday, February 17, 2021

In less than a decade, CRISPR has moved from breakthrough scientific paper to a Nobel Prize, because of its demonstrated power at accelerating the editing of genomes, particularly energizing efforts to treat patients in ways impossible before. This fireside chat with the CEO of Spotlight Therapeutics will explore the current frontier of clinical progress by CRISPR-based therapeutic approaches across a variety of indications, as well as new opportunities soon to be unlocked by next-generation CRISPR technologies.

Moderator
photo
Senior Editor
BioCentury Inc.
Speakers
photo
President and CEO
Spotlight Therapeutics Inc.
photo
Senior Editor
BioCentury Inc.